Effective stakeholder communication represents a key component of ensuring the impact of Lifescience and Health related progress and innovation
The message in each instance must be tailored to the stakeholder(s) to ensure comprehension of relevance and impact
Targeting all stakeholders this article discusses the necessity to not use the pre-existing models of value generation from healthcare products for regenerative medicine therapeutics or they will not become first line solutions, which is where their real value lies
In collaboration with a head of a patient association and a leading rare disease clinician, this 2013 article address the essential need to integrate in patient feedback into innovative product design throughout the whole process
EUROSTEMCELL was a complete project, coordinated by the University of Edinburgh, that we managed that focused on optimising communication of stem cell biology and therapeutics to all stakeholders; to inform policy, ensure GCP, appropriate ethics and prevent patient mis treatment
Written with two key opinion leaders in stem cells and biomaterials, this bioengineering focused article explains the key components of advanced therapeutic products and essential steps that need to be taken to ensure their uptake
Targeting every life science and health innovator throughout the total value chain, this one of many funding newsletter I generated informs and summarises for this stakeholder group solutions to enable the continued progression of their approaches
Written with two key opinion leaders in muscle stem cells and bioengineering, this article defines an ideal future of patient tailored and focused bioengineered products and how we will get there
An example of a final report written for a funding agency stakeholder, that required a concise public summary document of the key characteristics and progress of one of Europes largest bioengineering/regenerative medicine public-private partnership projects
For the same project as above, at the halfway point we made a decision to generate a public dissemination and easily understandable progress report highlighting key strategies, progress and future plans
For a global cardiovascular disease project focused on trying to use stem cells to repair cardiac damage, at its midterm we generated a short public summary and education document to inform the general public on the aims and progress of this project
Targeting industry, innovators, investors, funders and researchers, this short article summarised the peer reviewed publication into a short digestible format for these stakeholders to be able to fully understand the necessity include full value chain, health economics, indication specific factors and the clinical trial dynamics to obtain a more precise value for healthcare innovation development